Stock Events

Stock Events

Twist Bioscience 

M$3,255.37
305
+M$0.00+0%Wednesday 19:55

Statistics

Day High
3,255.37
Day Low
3,255.37
52W High
3,255.37
52W Low
3,255.37
Volume
5,224
Avg. Volume
-
Mkt Cap
215.83B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 12Expected
Q2 2026
Next
-9.7
-8.85
-8
-7.16
Expected EPS
-7.1556468024
Actual EPS
N/A

Financials

-21.45%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
7.36BRevenue
-1.58BNet Income

Analyst Ratings

$2,080.83Average Price Target
The highest estimate is ⁦2,924.04⁩.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
64%
Hold
27%
Sell
9%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TWST.MX. It's not an investment recommendation.
NVIDIA
92
NVDA
Microsoft
76
MSFT
Tesla
76
TSLA
Amazon
74
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap35.63B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with Twist Bioscience's synthetic DNA products.
Pacific Biosciences of California
PACB
Mkt Cap809.71M
Pacific Biosciences offers long-read sequencing technologies, competing with Twist Bioscience in the genomics and DNA sequencing market.
Agenus
AGEN
Mkt Cap308.91M
Agenus is involved in immuno-oncology, a field that relies on synthetic biology and genomics, areas where Twist Bioscience operates.
CRISPR Therapeutics
CRSP
Mkt Cap4.97B
CRISPR Therapeutics is focused on gene editing, a sector that directly competes with Twist Bioscience's synthetic DNA for research and therapeutic applications.
Editas Medicine
EDIT
Mkt Cap410.06M
Editas Medicine operates in the gene editing space, competing with Twist Bioscience in the development of genomic tools and therapies.
Intellia Therapeutics
NTLA
Mkt Cap1.75B
Intellia Therapeutics is another key player in the CRISPR/Cas9 gene editing technology, competing with Twist Bioscience in the genomic medicine field.
Adaptive Biotechnologies
ADPT
Mkt Cap4.25B
Adaptive Biotechnologies is engaged in the immune-driven medicine space, leveraging genomics and competing with Twist Bioscience in the use of synthetic DNA for immune system understanding.
Bionano Genomics
BNGO
Mkt Cap16.07M
Bionano Genomics provides tools for genomic analysis, competing in the broader genomics market where Twist Bioscience offers synthetic DNA solutions.

About

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Show More
CEO
Emily Marine Leproust
Employees
979
Country
United States
ISIN
US90184D1000
WKN
000A2N7L2

Listings

F
DE
0ME.F
STU
DE
0ME.STU
MU
DE
0ME.MU
XNAS
US
TWST

0 Comments

Share your thoughts

FAQs

What is Twist Bioscience stock price today?▼
The current price of TWST.MX is M$3,255.37 MXN — it has increased by +0% in the past 24 hours. Watch Twist Bioscience stock price performance more closely on the chart.
What is Twist Bioscience stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Mexican Exchange exchange Twist Bioscience stocks are traded under the ticker TWST.MX.
What is Twist Bioscience market cap?▼
Today Twist Bioscience has the market capitalization of 215.83B
When is the next Twist Bioscience earnings date?▼
Twist Bioscience is going to release the next earnings report on November 12, 2026.
What were Twist Bioscience earnings last quarter?▼
TWST.MX earnings for the last quarter are -9.7 MXN per share, whereas the estimation was -8.77 MXN resulting in a -10.62% surprise. The estimated earnings for the next quarter are N/A MXN per share.
What is Twist Bioscience revenue for the last year?▼
Twist Bioscience revenue for the last year amounts to 7.36B MXN.
What is Twist Bioscience net income for the last year?▼
TWST.MX net income for the last year is -1.58B MXN.
How many employees does Twist Bioscience have?▼
As of November 8, 2026, the company has 979 employees.
In which sector is Twist Bioscience located?▼
Twist Bioscience operates in the Health & Wellness sector.
When did Twist Bioscience complete a stock split?▼
Twist Bioscience has not had any recent stock splits.
Where is Twist Bioscience headquartered?▼
Twist Bioscience is headquartered in SOUTH SAN FRANCISCO, United States.